Alexion settles with SEC for over $21 million
Boston-based Alexion Pharmaceuticals has resolved alleged violations of the Foreign Corrupt Practices Act after a five-year investigation.
To read more
Subscribe to Global Investigations Review
Subscribe and start reading now
Global Investigations Review (GIR) is the hub for global coverage of corporate investigations and their aftermath. Keep up to date with significant developments in the corporate investigations world.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10